OTCPK:EMMBF - Post by User
Post by
anmckennon Mar 06, 2017 8:17am
262 Views
Post# 25935729
Price target raise based on real fundamentals
Price target raise based on real fundamentalsIn a research update to clients Monday, Zandberg maintained his Buy rating, but raised his one-year price target on Emblem Corp. from $3.50 to $3.75. The analyst believes Emblem will post EBITDA of negative $3.0-million on revenue of $7.56-million in fiscal 2017. He thinks these numbers will improve to positive EBITDA of $5.28-million on a topline of $29.67-million the following year. We continue to believe that Emblem will rank among the leading cannabis producers with a strong medical MJ strategy, says Zandberg.